• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表没食子儿茶素没食子酸酯(EGCG)在低氧状态下通过下调缺氧诱导因子-1α(HIF-1α)和血管内皮生长因子(VEGF)对胃癌SGC7901细胞增殖和凋亡的影响

Effects of EGCG on proliferation and apoptosis of gastric cancer SGC7901 cells via down-regulation of HIF-1α and VEGF under a hypoxic state.

作者信息

Fu J-D, Yao J-J, Wang H, Cui W-G, Leng J, Ding L-Y, Fan K-Y

机构信息

Department of Digestive Disease, People's Hospital of Rizhao, Affiliated Clinical Hospital of Jining Medical Univerity, Jining Medical University, Rizhao, Shandong, China.

出版信息

Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):155-161. doi: 10.26355/eurrev_201901_16759.

DOI:10.26355/eurrev_201901_16759
PMID:30657557
Abstract

OBJECTIVE

To investigate the effects of epigallocatechin-3-gallate (EGCG) on proliferation and apoptosis of human gastric cancer SGC7901 cells under a hypoxic state.

MATERIALS AND METHODS

Human gastric cancer SGC7901 cells were sub-cultured, and the cobalt chloride (CoCl2) hypoxia model was established. The blank control group (normoxia group), hypoxia control group (hypoxia group) and hypoxia + different concentrations of EGCG subgroups (20, 40, 60, 80, 100 μg/mL EGCG) were set up. Cell viability was detected via methyl thiazolyl tetrazolium (MTT) assay, apoptosis was detected via flow cytometry, and expressions of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) were detected via reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting.

RESULTS

Relatively low concentrations of EGCG (20-80 μg/mL) presented no significant inhibiting effect on SGC7901 cell growth within a short time (24 h) (p>0.05). The increasing concentration of EGCG inhibited cell proliferation under a hypoxia state (p<0.05). EGCG induced apoptosis in a dose-dependent manner under hypoxia (p<0.05). EGCG could significantly impede expressions of HIF-1α and VEGF proteins (p<0.05), and down-regulate the level of VEGF mRNA (p<0.05), but it showed no significant effect on the HIF-1α mRNA expression (p>0.05).

CONCLUSIONS

EGCG inhibited cell proliferation under hypoxia via the downregulation of HIF-1α and its downstream target gene VEGF levels, providing a theoretical basis for the early diagnosis and treatment of gastric cancer in clinic.

摘要

目的

探讨表没食子儿茶素-3-没食子酸酯(EGCG)对缺氧状态下人胃癌SGC7901细胞增殖和凋亡的影响。

材料与方法

对人胃癌SGC7901细胞进行传代培养,建立氯化钴(CoCl2)缺氧模型。设置空白对照组(常氧组)、缺氧对照组(缺氧组)和缺氧+不同浓度EGCG亚组(20、40、60、80、100μg/mL EGCG)。通过甲基噻唑基四氮唑(MTT)法检测细胞活力,通过流式细胞术检测细胞凋亡,通过逆转录-聚合酶链反应(RT-PCR)和蛋白质印迹法检测缺氧诱导因子-1α(HIF-1α)和血管内皮生长因子(VEGF)的表达。

结果

较低浓度的EGCG(20 - 80μg/mL)在短时间(24小时)内对SGC7901细胞生长无显著抑制作用(p>0.05)。EGCG浓度增加可抑制缺氧状态下的细胞增殖(p<0.05)。EGCG在缺氧条件下呈剂量依赖性诱导细胞凋亡(p<0.05)。EGCG可显著抑制HIF-1α和VEGF蛋白的表达(p<0.05),下调VEGF mRNA水平(p<0.05),但对HIF-1α mRNA表达无显著影响(p>0.05)。

结论

EGCG通过下调HIF-1α及其下游靶基因VEGF水平抑制缺氧状态下的细胞增殖,为临床胃癌的早期诊断和治疗提供了理论依据。

相似文献

1
Effects of EGCG on proliferation and apoptosis of gastric cancer SGC7901 cells via down-regulation of HIF-1α and VEGF under a hypoxic state.表没食子儿茶素没食子酸酯(EGCG)在低氧状态下通过下调缺氧诱导因子-1α(HIF-1α)和血管内皮生长因子(VEGF)对胃癌SGC7901细胞增殖和凋亡的影响
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):155-161. doi: 10.26355/eurrev_201901_16759.
2
Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.缺氧诱导因子-1α 沉默对 CBRH-7919 肝癌细胞增殖的影响。
World J Gastroenterol. 2013 Mar 21;19(11):1749-59. doi: 10.3748/wjg.v19.i11.1749.
3
The epigallocatechin gallate derivative Y inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways.没食子酸表没食子儿茶素酯衍生物 Y 通过抑制 MAPK/ERK1/2 和 PI3K/AKT/HIF-1α/VEGF 依赖性通路抑制血管生成来抑制人肝癌。
J Ethnopharmacol. 2020 Sep 15;259:112852. doi: 10.1016/j.jep.2020.112852. Epub 2020 Apr 9.
4
Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression.表没食子儿茶素-3-没食子酸酯通过下调HIF-1α和VEGF表达抑制IGF-I刺激的肺癌血管生成。
J Nutrigenet Nutrigenomics. 2013;6(3):169-78. doi: 10.1159/000354402. Epub 2013 Aug 31.
5
(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.(-)-表没食子儿茶素没食子酸酯通过靶向 HIF-1α 抑制人乳头瘤病毒(HPV)-16 癌蛋白诱导的非小细胞肺癌细胞血管生成。
Cancer Chemother Pharmacol. 2013 Mar;71(3):713-25. doi: 10.1007/s00280-012-2063-z. Epub 2013 Jan 6.
6
EGCG decreases the expression of HIF-1α and VEGF and cell growth in MCF-7 breast cancer cells.表没食子儿茶素没食子酸酯(EGCG)可降低MCF-7乳腺癌细胞中低氧诱导因子-1α(HIF-1α)和血管内皮生长因子(VEGF)的表达以及细胞生长。
J BUON. 2014 Apr-Jun;19(2):435-9.
7
Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1α and P-gp in the human pancreatic carcinoma cell line PANC-1.表没食子儿茶素没食子酸酯对人胰腺癌细胞株 PANC-1 细胞增殖及 HIF-1α 和 P-gp 表达的抑制作用。
Oncol Rep. 2012 May;27(5):1567-72. doi: 10.3892/or.2012.1697. Epub 2012 Feb 22.
8
[Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].[绿茶提取物对人乳头瘤病毒16型癌蛋白诱导的人宫颈癌细胞中缺氧诱导因子-1α和血管内皮生长因子表达的影响]
Zhonghua Yi Xue Za Zhi. 2008 Nov 4;88(40):2872-7.
9
Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.缺氧诱导因子-1α的敲低可降低视网膜母细胞瘤WERI-Rb-1细胞在缺氧条件下的增殖,诱导其凋亡并减弱其侵袭性表型。
Ann Clin Lab Sci. 2014 Spring;44(2):134-44.
10
Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.绿茶提取物和(-)-表没食子儿茶素-3-没食子酸酯可抑制人宫颈癌和肝癌细胞中缺氧及血清诱导的HIF-1α蛋白积累和VEGF表达。
Mol Cancer Ther. 2006 May;5(5):1227-38. doi: 10.1158/1535-7163.MCT-05-0490.

引用本文的文献

1
Natural anti-cancer products: insights from herbal medicine.天然抗癌产品:来自草药医学的见解。
Chin Med. 2025 Jun 9;20(1):82. doi: 10.1186/s13020-025-01124-y.
2
Alternative medicines in oncology: a focus on natural products against gastric cancer.肿瘤学中的替代医学:聚焦于抗胃癌的天然产物
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 22. doi: 10.1007/s00210-025-04058-2.
3
Exploring natural products as apoptosis modulators in cancers: insights into natural product-based therapeutic strategies.探索天然产物作为癌症中的细胞凋亡调节剂:对基于天然产物的治疗策略的见解。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 27. doi: 10.1007/s00210-025-03876-8.
4
Immunomodulatory Effects of Green Tea Catechins and Their Ring Fission Metabolites in a Tumor Microenvironment Perspective.从肿瘤微环境角度探讨绿茶儿茶素及其环裂代谢物的免疫调节作用。
Molecules. 2024 Sep 26;29(19):4575. doi: 10.3390/molecules29194575.
5
Steady-State Delivery and Chemical Modification of Food Nutrients to Improve Cancer Intervention Ability.食物营养素的稳态递送与化学修饰以提高癌症干预能力。
Foods. 2024 Apr 28;13(9):1363. doi: 10.3390/foods13091363.
6
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets.以表没食子儿茶素没食子酸酯(EGCG)靶向癌症特征:机制基础和治疗靶点。
Molecules. 2024 Mar 20;29(6):1373. doi: 10.3390/molecules29061373.
7
The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.没食子儿茶素没食子酸酯在肿瘤微环境、代谢重编程和免疫治疗中的作用。
Front Immunol. 2024 Jan 29;15:1331641. doi: 10.3389/fimmu.2024.1331641. eCollection 2024.
8
Application of temperature-sensitive liquid embolic agent loaded with oxaliplatin in the TACE procedure for rabbit VX2 gastric cancer.载奥沙利铂温敏液体栓塞剂在兔 VX2 胃癌 TACE 术中的应用。
Drug Deliv Transl Res. 2024 Mar;14(3):705-717. doi: 10.1007/s13346-023-01425-5. Epub 2023 Sep 5.
9
Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications.没食子酸表没食子儿茶素酯在癌症治疗中的潜力:作用机制与临床意义。
Molecules. 2023 Jul 6;28(13):5246. doi: 10.3390/molecules28135246.
10
Anticancer applications of phytochemicals in gastric cancer: Effects and molecular mechanism.植物化学物在胃癌中的抗癌应用:作用及分子机制
Front Pharmacol. 2023 Jan 12;13:1078090. doi: 10.3389/fphar.2022.1078090. eCollection 2022.